Application
Western blot analysis of CLDN15 Antibody (Center) in K562 cell line lysates (35ug/lane). CLDN15 (arrow) was detected using the purified Pab.Application
CLDN15 Antibody (Center) flow cytometric analysis of K562 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | CLDN15 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CLDN15; Claudin-15 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | CLDN15 Claudin-15 |
|---|---|
| Molecular Weight(MW) | 24356 Da |
| Function | Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium- independent cell-adhesion activity (By similarity) |
| Tissue Specificity | This CLDN15 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 135~165 amino acids from the Central region of human CLDN15. |
| Cellular Localization | Cell junction, tight junction. Cell membrane; Multi-pass membrane protein |
| Entrez Gene | 24146 |
|---|
Application
Western blot analysis of CLDN15 Antibody (Center) in K562 cell line lysates (35ug/lane). CLDN15 (arrow) was detected using the purified Pab.
Application
CLDN15 Antibody (Center) flow cytometric analysis of K562 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
